Yuan B Z, Miller M J, Keck C L, Zimonjic D B, Thorgeirsson S S, Popescu N C
Laboratory of Experimental Carcinogenesis, Division of Basic Sciences, National Cancer Institute, NIH, Bethesda, Maryland 20892-4255, USA.
Cancer Res. 1998 May 15;58(10):2196-9.
The isolation of genes involved in cancer development is critical for uncovering the molecular basis of cancer. We report here the isolation of the full-length cDNA and chromosomal localization of a new gene frequently deleted in liver cancer (DLC-1) that was identified by representational difference analysis. Loss of heterozygosity was detected for DLC-1 in 7 of 16 primary hepatocellular carcinomas (HCCs) and in 10 of 11 HCC cell lines. Although mRNA for DLC-1 was expressed in all normal human tissues, it was not expressed in 4 of 14 HCC cell lines. Full-length cDNA for DLC-1 of 3800 bp encodes a protein of 1091 amino acids, has 86% homology with rat p122 RhoGAP gene, and was localized by fluorescence in situ hybridization on chromosome 8 at bands p21.3-22. Deletions on the short arm of chromosome 8 are recurrent in liver, breast, lung, and prostate cancers, suggesting the presence of tumor suppressor genes. DLC-1 may be a tumor suppressor gene in liver cancer as well as in other cancers.
分离参与癌症发展的基因对于揭示癌症的分子基础至关重要。我们在此报告通过代表性差异分析鉴定出的一个在肝癌中经常缺失的新基因(DLC-1)的全长cDNA分离及染色体定位。在16例原发性肝细胞癌(HCC)中的7例以及11株HCC细胞系中的10株中检测到DLC-1的杂合性缺失。尽管DLC-1的mRNA在所有正常人体组织中均有表达,但在14株HCC细胞系中的4株中未表达。3800 bp的DLC-1全长cDNA编码一个含1091个氨基酸的蛋白质,与大鼠p122 RhoGAP基因有86%的同源性,并通过荧光原位杂交定位在8号染色体的p21.3 - 22带。8号染色体短臂的缺失在肝癌、乳腺癌、肺癌和前列腺癌中经常出现,提示存在肿瘤抑制基因。DLC-1可能是肝癌以及其他癌症中的一个肿瘤抑制基因。